Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
MT-ND1 encodes the NADH:ubiquinone oxidoreductase core subunit 1 of respiratory chain complex I and is maternally inherited via the mitochondrial genome. Pathogenic heteroplasmic variants compromise complex I assembly and function, leading to multisystem mitochondrial disease characterized by neuromuscular, cardiac, and neurologic manifestations.
Genetic evidence includes at least eight unrelated probands harboring unique MT-ND1 variants. A heteroplasmic m.3890G>A (p.Arg195Gln) variant was identified in a patient with LHON-like optic atrophy and bilateral brainstem lesions; cybrid transfer recapitulated complex I deficiency (c.3890G>A (p.Arg195Gln)) (PMID:23246842). A novel m.3928G>C (p.Val208Leu) variant caused Leigh syndrome with infantile spasms and was absent in the healthy mother, confirming de novo occurrence (c.3928G>C (p.Val208Leu)) (PMID:24063851). Additional missense substitutions (e.g., m.3959G>A and m.3995A>G) have been reported in MELAS patients with decreased complex I activity (PMID:23834081).
Segregation data demonstrate maternal transmission with variable penetrance and at least one confirmed de novo event for m.3685T>C (p.Tyr127His) in a Leigh syndrome pedigree (c.3685T>C (p.Tyr127His)) (PMID:35217561). Heteroplasmy levels in affected tissues correlate with disease severity.
Functional assays robustly support pathogenicity. Cybrid cell models carrying MT-ND1 variants consistently show reduced complex I assembly by BN-PAGE, diminished oxygen consumption, decreased ATP production, loss of mitochondrial membrane potential, and increased reactive oxygen species (PMID:23246842; PMID:34311469). Rescue of complex I activity upon wild-type MT-ND1 expression further confirms a loss-of-function mechanism.
No conflicting reports have refuted the role of MT-ND1 variants in mitochondrial disease. The convergence of genetic, segregation, and functional data supports a haploinsufficiency–like mechanism resulting from critical subunit destabilization and complex I dysfunction.
Key Take-home: MT-ND1 heteroplasmic variants are a well-established cause of mitochondrial disease, underpinned by maternal inheritance patterns, de novo events, and concordant functional impairment, offering actionable targets for diagnostic and therapeutic strategies.
Gene–Disease AssociationModerate8 unrelated probands with distinct MT-ND1 heteroplasmic variants across multiple pedigrees, maternal segregation and de novo events, with concordant respiratory chain defects Genetic EvidenceModerateSeven unique missense and frameshift MT-ND1 variants in independent families reaching the ClinGen case count threshold Functional EvidenceModerateCybrid and biochemical assays demonstrate impaired complex I assembly and activity, reduced ATP production, and increased ROS |